FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

Nova Allegro UACR Assay, Nova Allegro Analyzer

K Number: K252206 · Decision Jan 9, 2026
Classifications
1
FEI Numbers
39
Registration Numbers
39
Same Product Code
158
Applicant Total
40
Review Days
179

Basic Information

Device Name
Nova Allegro UACR Assay, Nova Allegro Analyzer
K Number
K252206
Device Class
FDA class 2
Clearance Type
Dual Track
Regulation Number
862.1225
Medical Specialty
Clinical Chemistry
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Nova Biomedical Corporation
Date Received
July 14, 2025
Decision Date
January 9, 2026
Product Code
CGX
Advisory Committee
Clinical Chemistry
Review Advisory Committee
CH
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
CGX Alkaline Picrate, Colorimetry, Creatinine

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (CGX), ordered by most recent decision date.

View all

Other Clearances by Nova Biomedical Corporation

K Number Device Name
K251281 Nova Max Creat eGFR Monitoring System
K221326 Nova Allegro HbA1c Assay, Nova Allegro Analyzer
K221813 Nova Allegro UACR Assay, Nova Allegro Analyzer
K232075 StatStrip Glucose Hospital Meter System
K221900 Stat Profile Prime Plus Analyzer System
K203549 Nova Primary Glucose Analyzer System
K200403 Stat Profile Prime Plus Analyzer System
K200204 Stat Profile Prime Plus Analyzer System
K200349 Stat Profile Prime Plus Analyzer System
K193246 Stat Profile Prime Plus Analyzer System
Search all 40 clearances from Nova Biomedical Corporation →